Yemi Oluboyede
Overview
Explore the profile of Yemi Oluboyede including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robinson T, Hill S, Oluboyede Y
Value Health
. 2025 Jan;
PMID: 39880199
Objectives: The Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE) is a weight-specific patient-reported outcome measure for use in adolescence, consisting of 7 domains, each with 5 response levels. The objective...
2.
Dennis N, Dunton K, Livings C, Bogoeva N, Bourke S, Oluboyede Y, et al.
Eur J Cancer
. 2025 Jan;
217:115192.
PMID: 39798264
Objective: DESTINY-Breast03, a randomised, phase 3 trial, evaluated trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients with human epidermal growth factor receptor (HER2)-positive unresectable and/or metastatic breast cancer who...
3.
Patel A, Toro W, Bourke S, Oluboyede Y, Barbier S, Bogoeva N, et al.
PLoS One
. 2024 Oct;
19(10):e0309666.
PMID: 39432490
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder characterized by skeletal muscle weakness and atrophy. Patients with SMA types 1 and 2 develop severe disabilities conferring substantial patient and...
4.
Besser M, OSullivan S, Bourke S, Longworth L, Barcelos G, Oluboyede Y
J Patient Rep Outcomes
. 2024 Sep;
8(1):110.
PMID: 39325265
Background: Sickle cell disease (SCD), a genetic blood disorder that affects red blood cells and oxygen delivery to body tissues, is characterized by haemolytic anaemia, pain episodes, fatigue, and end-organ...
5.
Bourke S, Bennett B, Oluboyede Y, Li T, Longworth L, OSullivan S, et al.
Health Qual Life Outcomes
. 2024 Sep;
22(1):81.
PMID: 39304893
Background: The minimal important difference (MID) is a useful tool to interpret changes in patients' health-related quality of life. This study aims to estimate MIDs for interpreting within-patient change for...
6.
Carrie S, Fouweather T, Homer T, OHara J, Rousseau N, Rooshenas L, et al.
Health Technol Assess
. 2024 Mar;
28(10):1-213.
PMID: 38477237
Background: The indications for septoplasty are practice-based, rather than evidence-based. In addition, internationally accepted guidelines for the management of nasal obstruction associated with nasal septal deviation are lacking. Objective: The...
7.
Hill S, Gibson A, Oluboyede Y, Longworth L, Bennett B, Shaw J
Value Health
. 2024 Mar;
27(6):784-793.
PMID: 38467189
Objectives: Time trade-off (TTO) and discrete choice experiment (DCE) preference-elicitation techniques can be administered using face-to-face interviews (F2F), unassisted online (UO) surveys, or remote-assisted (RA) interviews. The objective of this...
8.
Ahmed W, Longworth L, Oluboyede Y, Cain P, Amorosi S, Hill S, et al.
Health Qual Life Outcomes
. 2024 Mar;
22(1):24.
PMID: 38448967
Background: Health-state utility values (HSUVs) for post-transplant refractory cytomegalovirus (CMV) infection (with or without resistance [R/R]) were determined using a time trade-off (TTO) survey completed by 1,020 members of the...
9.
Robinson T, Hill S, Orozco-Leal G, Kernohan A, King W, Oluboyede Y
J Patient Rep Outcomes
. 2024 Jan;
8(1):6.
PMID: 38214796
Purpose: The Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE) is a physical weight-specific patient reported outcome measure for use in adolescence. The purpose of this study was to use the...
10.
Carrie S, OHara J, Fouweather T, Homer T, Rousseau N, Rooshenas L, et al.
BMJ
. 2023 Oct;
383:e075445.
PMID: 37852641
Objective: To assess the clinical effectiveness of septoplasty. Design: Multicentre, randomised controlled trial. Setting: 17 otolaryngology clinics in the UK's National Health Service. Participants: 378 adults (≥18 years, 67% men)...